|
 |
J Clin Outcomes Manage
2009 Apr;16(4):181-195
The abnormal pap test: update on evaluation, treatment, and monitoring
Tenney ME, Moore KN
Program Audience Primary care physicians. Educational Needs Addressed Cervical cancer is the second most common female cancer after breast cancer. Unlike many other cancers, however, it is largely preventable through screening and vaccination. While most physicians in the primary care setting perform Pap tests and are aware of published screening guidelines, adherence to published guidelines varies considerably, and cervical screening rates are unacceptably low. Evidence-based guidelines for the management of abnormal cervical cytologic results have been published. Proper use of human papillomavirus (HPV) testing improves the management of women with cytologic abnormalities and may reduce morbidity and mortality in a cost-effective manner. Although many U.S. clinicians reported using HPV tests according to guidelines, many also reported inappropriate use. Educational Objectives After participating in this CME activity, primary care physicians should be able to 1. Explain the recommended timing and strategy for cervical cancer screening 2. Describe the role of HPV DNA testing in cervical cancer prevention 3. Describe the management algorithms for abnormal cervical cytologic results in adult and adolescent patients 4. Describe the utility of HPV vaccination
Case-based review
Search the Turner White index to find abstracts of articles published in JCOM.
|
